HawaiiHB 2162025–2026 Regular Session (Year 2)House

RELATING TO PRESCRIPTION DRUGS.

Sponsored By: Gregg Takayama (Democratic)

In Committee

Summary

Establishes requirements for the clinical review criteria and clinical practical guidelines used to establish step therapy protocols. Provides a process for a patient to request an exception to using step therapy protocols. Establishes insurance coverage requirements relating to the use of step therapy protocols and standards to appeal an adverse step therapy exception determination.

Health InsurancePrescription DrugsStep Therapy ProtocolClinical Review CriteriaClinical Practice GuidelinesExceptionsHLT, CPC, FIN

Your PRIA Score

Score Hidden

Personalized for You

How does this bill affect your finances?

Sign up for a PRIA Policy Scan to see your personalized alignment score for this bill and every other piece of legislation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.

Free to start

Bill Overview

No Economic Impacts Identified for this Bill

Sponsors & Cosponsors

Sponsor

  • Gregg Takayama

    Democratic • House

Cosponsors

  • Darius K. Kila

    Democratic • House

  • Lisa Kitagawa

    Democratic • House

  • Lauren Matsumoto

    Republican • House

  • Elijah Pierick

    Republican • House

  • Jenna Takenouchi

    Democratic • House

  • Adrian K. Tam

    Democratic • House

Roll Call Votes

No roll call votes available for this bill.

Actions Timeline

  1. Carried over to 2026 Regular Session.

    12/8/2025
  2. Referred to HLT, CPC, FIN, referral sheet 1

    1/21/2025House
  3. Introduced and Pass First Reading.

    1/16/2025House
  4. Pending introduction.

    1/15/2025House

Bill Text

Related Bills

Back to State Legislation